Table 2.
Group 1 (n = 32) | Group 2 (n = 32) | P (MWU) | |
Pain (VAS 0–10 cm)Baseline3rd week12th week | pA 7.09 ± 1.67 3.62 ± 2.59 † <0.001*4.78 ± 2.80 ‡ | pA7.37 ± 1.694.43 ± 2.39 † <0.001* 6.25 ± 2.44 ‡ | 0.570.190.02* |
Change (0–12) | 2.31 ± 2.30 | 1.12 ± 1.99 | 0.03* |
Function (NPDS) | pA | pA | |
Baseline | 60.25 ± 17.01 | 61.12 ± 19.47 | 0.84 |
3rd week | 42.03 ± 21.58 † <0.001* | 44.53 ± 20.81 † <0.001* | 0.63 |
12th week | 48.37 ± 22.30 ‡ | 54.34 ± 20.74 ‡ | 0.27 |
MWU: Mann–Whitney U test, A: ANOVA, †: baseline - 3rd week, ‡: baseline - 12th week differences within groups (Wilcoxon signed ranks test/paired samples test), * P < 0.05.